Orphapacket:
  AverageAgeOfOnsets:
  - AverageAgeOfOnset:
      value: Adolescent
  - AverageAgeOfOnset:
      value: Adult
  - AverageAgeOfOnset:
      value: Childhood
  - AverageAgeOfOnset:
      value: Elderly
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - DisorderMappingRelation: 'E (Exact mapping: the two concepts are equivalent)'
    Reference: '143100'
    Source: OMIM
  Genes:
  - Gene:
      DisorderGeneAssociationType: Disease-causing germline mutation(s) (gain of function)
        in
      ExternalReferences: []
      Name: huntingtin
      Symbol: HTT
  - Gene:
      DisorderGeneAssociationType: Modifying germline mutation in
      ExternalReferences: []
      Name: solute carrier family 2 member 3
      Symbol: SLC2A3
  Label: Huntington disease
  ORPHAcode: '399'
  ORPHApacketId: '399'
  PURL: http://www.orpha.net/ORDO/Orphanet_399
  Parents:
  - Parent:
    - Label: Rare genetic neuromuscular disorder with ocular motility/alignment anomaly
      ORPHAcode: '522522'
  - Parent:
    - Label: Genetic neurodegenerative disease with dementia
      ORPHAcode: '276058'
  - Parent:
    - Label: Neurodegenerative disease with chorea
      ORPHAcode: '306719'
  - Parent:
    - Label: Neurodegenerative disease with dementia
      ORPHAcode: '98534'
  - Parent:
    - Label: Rare neuromuscular disorder with ocular motility/alignment anomaly
      ORPHAcode: '519347'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001268
      HPOTerm: Mental deterioration
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001347
      HPOTerm: Hyperreflexia
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002072
      HPOTerm: Chorea
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000496
      HPOTerm: Abnormality of eye movement
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000713
      HPOTerm: Agitation
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000716
      HPOTerm: Depression
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000718
      HPOTerm: Aggressive behavior
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000722
      HPOTerm: Obsessive-compulsive behavior
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000734
      HPOTerm: Disinhibition
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000737
      HPOTerm: Irritability
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000738
      HPOTerm: Hallucinations
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000739
      HPOTerm: Anxiety
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000741
      HPOTerm: Apathy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000746
      HPOTerm: Delusions
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001250
      HPOTerm: Seizure
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001288
      HPOTerm: Gait disturbance
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001332
      HPOTerm: Dystonia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001336
      HPOTerm: Myoclonus
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001824
      HPOTerm: Weight loss
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002067
      HPOTerm: Bradykinesia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002141
      HPOTerm: Gait imbalance
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002312
      HPOTerm: Clumsiness
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002354
      HPOTerm: Memory impairment
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002355
      HPOTerm: Difficulty walking
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002375
      HPOTerm: Hypokinesia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0003324
      HPOTerm: Generalized muscle weakness
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0004305
      HPOTerm: Involuntary movements
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0004408
      HPOTerm: Abnormality of the sense of smell
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0007010
      HPOTerm: Poor fine motor coordination
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0009088
      HPOTerm: Speech articulation difficulties
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0025401
      HPOTerm: Staring gaze
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0031473
      HPOTerm: Hostility
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0031843
      HPOTerm: Bradyphrenia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0031845
      HPOTerm: Abnormal libido
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001262
      HPOTerm: Excessive daytime somnolence
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002059
      HPOTerm: Cerebral atrophy
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002063
      HPOTerm: Rigidity
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002169
      HPOTerm: Clonus
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002300
      HPOTerm: Mutism
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002340
      HPOTerm: Caudate atrophy
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002500
      HPOTerm: Abnormal cerebral white matter morphology
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002540
      HPOTerm: Inability to walk
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002591
      HPOTerm: Polyphagia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0003107
      HPOTerm: Abnormality of cholesterol metabolism
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0003487
      HPOTerm: Babinski sign
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0010794
      HPOTerm: Impaired visuospatial constructive cognition
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0030842
      HPOTerm: Choking episodes
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0030955
      HPOTerm: Alcoholism
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0031589
      HPOTerm: Suicidal ideation
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0040140
      HPOTerm: Degeneration of the striatum
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0045082
      HPOTerm: Decreased body mass index
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0100785
      HPOTerm: Insomnia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0200136
      HPOTerm: Oral-pharyngeal dysphagia
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Greece
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21166788[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 22692795[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 22692795[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: European Medicines Agency 2019[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Ireland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 20880124[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 22133668[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 22133668[PMID]_21088431[PMID]_7994530[PMID]_9231935[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 2151397[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 2151397[PMID]_25689972[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Canada
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 11595021[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 8018043[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 8018043[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Japan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 8700304[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Australia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 11008591[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Australia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 11008591[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: China
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 7586664[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: China
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 7586664[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Slovenia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 18976322[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Taiwan, Province of China
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 7586664[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Taiwan, Province of China
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 7586664[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Iceland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 22722209[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Iceland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 22722209[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 2938203[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Sweden
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 22722209[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Greece
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 21166788[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 2889026[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Egypt
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 7969703[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Cyprus
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29105741[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Cyprus
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 29105741[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Denmark
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 28155235[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 33568143[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 33568143[PMID]
      ValMoy: no data
  Synonyms:
  - Synonym: Huntington chorea
  TextSection:
    Contents: Huntington disease (HD) is a rare neurodegenerative disorder of the
      central nervous system characterized by unwanted choreatic movements behavioral
      and psychiatric disturbances and dementia.
    TextSectionType: Definition
  TypeOfInheritances:
    TypeOfInheritance:
    - value: Autosomal dominant
  copyright: Orphanet (c) 2024
  creationDate: '2024-07-01 09:48:26'
  version: 1.3.29 / 4.1.7 [2023-08-02] (orientdb version)
